Repligen
RGEN
164 hedge funds and large institutions have $560M invested in Repligen in 2014 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 57 increasing their positions, 63 reducing their positions, and 20 closing their positions.
139% more call options, than puts
Call options by funds: $14.3M | Put options by funds: $5.98M
10% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 20
1% more funds holding
Funds holding: 163 → 164 (+1)
10% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 63
13% less capital invested
Capital invested by funds: $641M → $560M (-$80.8M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| 1 |
O
OppenheimerFunds
New York
|
+$11.9M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$8.64M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$4.14M |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$3.16M |
| 5 |
Renaissance Technologies
New York
|
+$3.12M |
Top Sellers
RGEN Hedge Fund Activity: Q3 2014 in Review
164 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q3 2014, worth a combined $560M — down 13% from $641M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new RGEN positions and 20 closed out — a net gain of 2 holders — while 57 added to existing stakes and 63 trimmed.
The largest buyer was OppenheimerFunds, opening a new position worth an estimated $11.9M. The largest seller was Bogle Investment Management, cutting an estimated $7.83M.
- 164 institutional investors held Repligen (RGEN) as of Q3 2014, up from 163 in Q2 2014.
- Funds reported $560M of Repligen stock for Q3 2014, down 13% quarter-over-quarter.
- 22 funds opened new Repligen positions in Q3 2014 and 20 closed out, a net change of +2 holders.
- The largest Repligen buyer in Q3 2014 was OppenheimerFunds, an estimated $11.9M added.
- The largest Repligen seller in Q3 2014 was Bogle Investment Management, an estimated $7.83M sold.
Based on aggregated 13F filings for Q3 2014.